ArticleJournal of diabetes science and technology2017
Impact of Disease Management Programs on HbA1c Values in Type 2 Diabetes Patients in Germany.
Article in Journal of diabetes science and technology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 26 citations in OpenAlex.
- Article
- [Osteoporosis-risk evaluation and case finding].Orthopadie (Heidelberg, Germany) · 2023Review
- [Photo-based examination for diabetic eye pathologies in a German ophthalmological practice without personal doctor-patient contact].Die Ophthalmologie · 2023Article
- Metabolic Control, Diabetic Complications and Drug Therapy in a Cohort of Patients with Type 1 and Type 2 Diabetes in Secondary and Tertiary Care between 2004 and 2019.International journal of environmental research and public health · 2023Article
- Article
- Screening cardiovascular risk factors of diabetes patients in the primary diabetes clinics.Medicine · 2021Observational
- Effects of Point-Of-Care Testing in General Practice for Type 2 Diabetes Patients on Ambulatory Visits and Hospitalizations.International journal of environmental research and public health · 2020Article
- Therapeutic Inertia: Still a Long Way to Go That Cannot Be Postponed.Diabetes spectrum : a publication of the American Diabetes Association · 2020Article
- [Treatment of osteoporosis in the outpatient field : Possibilities and challenges].Der Unfallchirurg · 2019Review
- Association between full monitoring of biomedical and lifestyle target indicators and HbABMJ open · 2019Observational
- Seasonality of Insulin Use in German Outpatients With Diabetes: A Retrospective Analysis.Journal of diabetes science and technology · 2017Article
- Risk of Nonfatal Stroke in Type 2 Diabetes Mellitus Patients: A Retrospective Comparison Between Disease Management Programs and Standard Care.Journal of diabetes science and technology · 2017Article
- Impact of diabetes on outcome in critical limb ischemia with tissue loss: a large-scaled routine data analysis.Cardiovascular diabetology · 2017Article
- Disease management programs for patients with type 2 diabetes mellitus in Germany: a longitudinal population-based descriptive study.Diabetology & metabolic syndrome · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe aim was to analyze the impact of disease management programs on HbA1c values in type 2 diabetes mellitus (T2DM) patients in Germany.
methodsThis study included 9017 patients followed in disease management programs (DMPs) who started an antihyperglycemic treatment upon inclusion in a DMP. Standard care (SC) patients were included after individual matching (1:1) to DMP cases based on age, gender, physician (diabetologist versus nondiabetologist care), HbA1c values at baseline, and index year. The main outcome was the share of patients with HbA1c <7.5% or 6.5% after at least 6 months and less than 12 months of therapy in DMP and SC groups. Multivariate logistic regression models were fitted with HbA1c level as a dependent variable and the potential predictor (DMP versus SC).
resultsThe mean age was 64.3 years and 54.7% of the patients were men. The mean HbA1c level at baseline was equal to 8.7%. In diabetologist practices, 64.7% of DMP patients and 55.1% of SC patients had HbA1c levels <7.5%, while 23.4% of DMP patients and 16.9% of SC patients had HbA1c levels <6.5% ( P values < .001). By comparison, in general practices, 72.4% of DMP patients and 65.7% of SC patients had HbA1c levels <7.5%, while 29.0% of DMP patients and 25.4% of SC patients had HbA1c levels <6.5% ( P values < .001). DMPs increased the likelihood of HbA1c levels lower than 7.5% or 6.5% after 6 months of therapy in both diabetologist and general care practices.
conclusionThe present study indicates that the enrollment of T2DM patients in DMPs has a positive impact on HbA1c values in Germany.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.